跳至主要内容
临床试验/JPRN-UMIN000001071
JPRN-UMIN000001071已完成未知

Efficacy of Ezetimibe for the patients with Non-alcoholic fatty liver disease (NAFLD) - Ezetimibe therapy for Non-alcoholic fatty liver disease (NAFLD)

Osaka City University Graduate School of Medicine0 个研究点目标入组 60 人开始时间: 2011年6月30日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
60

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. past history of hypersensitivity to Ezetimibe 2. clinical sighs of severe liver injury such as acute hepatitis, acute exacerbation of chronic hepatitis, cirrhosis in Child B or C, hepatocellular carcinoma, and jaundice in combination with Statin. 3. women who are or possibly pregnant 4. past history of atherosclerotic disease(myocardial infarction , angina pectoris, cerebral stroke, and so on). 5. secondry hyperlipidemia or drug induced hyperlipidemia

研究者

发起方
Osaka City University Graduate School of Medicine

相似试验

Efficacy of Ezetimibe for the patients with... | 临床试验